Cargando…
Docetaxel/cisplatin Therapy in Myasthenia Gravis with Hypertension/diabetes
BACKGROUND: Therapeutic options for thymoma-associated myasthenia gravis (MG) patients complicated with hypertension and/or diabetes post thymectomy are often conventional steroids. As the prevalence of diabetes and hypertension globally increases, other therapeutic options for these patients are of...
Autores principales: | Qi, Guoyan, Xue, Yinping, Li, Yongzhao, Yang, Hongxia, Zhang, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757353/ https://www.ncbi.nlm.nih.gov/pubmed/29318185 http://dx.doi.org/10.1515/med-2017-0058 |
Ejemplares similares
-
Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment
por: Yang, Hongxia, et al.
Publicado: (2023) -
Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent
por: Qi, Guoyan, et al.
Publicado: (2017) -
Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence
por: Cheng, Biqi, et al.
Publicado: (2022) -
Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis
por: Liu, Peng, et al.
Publicado: (2021) -
Analysis of clinical features of myasthenia gravis complicated with hyperthyroidism
por: Wang, Yaxuan, et al.
Publicado: (2022)